Announcing Research 101 | UMR Answers Common Questions About NIH Research in this New Fact Sheet Series
Why Invest in NIH Research? | UMR Offers Fact Sheets Explaining Why Congress Must #keepNIHstrong
Read UMR's Statement on the House Appropriations Committee's Passage of FY23 Labor-HHS Funding Bill
NIH's Role In Sustaining the U.S. Economy | 2022 Update Now Available

A participant in the NIH 2019-2020 Medical Research Scholars Program.

Photo Credit: National Institutes of Health

About This Photo

House Appropriations Subcommittee Markup Provides Needed Boost to NIH Biomedical Research Funding

July 21, 2010

Statement of Gregory T. Lucier, United for Medical Research spokesperson and Chairman and Chief Executive Officer of Life Technologies

WASHINGTON – “On behalf of United for Medical Research (UMR), a coalition of leading research institutions, patient and health advocates and private industry, I applaud Chairman Obey and the House Appropriations Subcommittee for their approval of $32 billion for the National Institutes of Health (NIH) FY2011 budget. Today’s markup provides a significant step forward toward increased investment in life-saving and economy-boosting medical research funding.

“NIH funds are not just a vital tool in our pursuit to reduce the burden of disease and its associated health care costs, but also yield essential dividends in our states and communities – from job creation and industry growth to better quality of life for millions of patients and families.

“On behalf of UMR, I commend Chairman Obey’s leadership and the appropriations subcommittee action and urge Congress to continue moving forward and secure a significant funding increase for the NIH.